Greenrose(OTC) GNRS

Market CapN/A

Since IPO (2020)-100%

5 Year-100%

1 Year+0%

1 Month+0%

N/A

Greenrose last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-08-12

Greenrose stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.00	2026-07-24
1 month	+0%	USD 0.00	2026-06-24
3 month	+0%	USD 0.00	2026-04-30
Year to date	+0%	USD 0.00	2025-12-31
1 year	+0%	USD 0.00	2025-08-11
3 year	-99.8%	USD 0.00	2023-08-11
5 year	-100%	USD 10.01	2021-08-13
Since inception	-100%	USD 9.61	2020-05-21

Greenrose Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$50.62M

Net Income (TTM)

-$40.10M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Aug 20, 2024

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Aug 20, 2024

GNRS News

Marijuana leaf with U.S. flag in the background.

This Hot New Cannabis SPAC Gives Investors Exposure to Some of the Hottest Markets

David Jagielski, CPAMar 25, 2021

This SPAC Is Buying 4 Companies to Build a Vertically Integrated Cannabis Network

Rich DupreyMar 15, 2021

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Greenrose

The Greenrose Holding Company Inc. is a cannabis-focused enterprise based in Amityville, New York. Established in 2014, the company specializes in the cultivation, processing, and distribution of medical cannabis products through its subsidiaries.

Products and Services

Manufacturing of medical cannabis products
Processing and packaging of cannabis derivatives
Distribution of cannabis-related items

Growth Outlook

Recent revenue of $7.85 million in Q3 2022 indicates market demand
Significant gross profit margin of 33.2% in Q3 2022
Expansion potential in the growing cannabis industry

Financial Highlights

Trailing twelve months (TTM) revenue of $28.5 million
Net profit margin of 70.6% reflects operational efficiency
Current ratio of 0.21 suggests liquidity challenges

The Greenrose Holding Company Inc. operates in the rapidly evolving cannabis sector, which has seen increasing acceptance and demand for medical cannabis products. The company's recent quarterly performance shows a revenue of $7.85 million, highlighting its ability to capture market interest. The gross profit margin of 33.2% in Q3 2022 indicates a solid foundation for profitability, despite the challenges faced in the broader market. The trailing twelve months revenue of $28.5 million demonstrates the company's capacity to generate substantial income, while the impressive net profit margin of 70.6% showcases its operational efficiency. However, the current ratio of 0.21 raises concerns about liquidity, suggesting that the company may need to address short-term financial obligations. Overall, The Greenrose Holding Company Inc. presents a compelling opportunity within the cannabis industry, with significant growth potential and a strong focus on medical cannabis products.

AI Generated • Jul 31, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

Timothy Bossidy, MBA

Website

www.greenrosecorp.com

Headquarters

Amityville, NY 11701, US

GNRS Financials

Key Financial Metrics (TTM)

Gross Margin

59.05%

Operating Margin

38.74%

Net Income Margin

70.59%

Return on Equity

14.83%

Return on Capital

5.54%

Return on Assets

7.50%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$23.70M

Operating Income

-$4.12M

EBITDA

$7.92M

Operating Cash Flow

$4.44M

Capital Expenditure

-$1.47M

Free Cash Flow

$2.97M

Cash & ST Invst.

$962.00K

Total Debt

$141.89M

Greenrose Performance Analysis

Greenrose annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2021	2021-12-31	USD 25,395,000	N/A

Greenrose sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2021-12-31	N/A
Q1	2022-03-31	-67.8%
Q2	2022-06-30	12.2%
Q3	2022-09-30	-14.6%

Greenrose annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2021	2021-12-31	USD 0.99	N/A

Greenrose sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q4	2021-12-31	103.7%
Q1	2022-03-31	-757.1%
Q2	2022-06-30	31.5%
Q3	2022-09-30	-246.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q3 2022YOY CHG

Revenue

$7.85M

N/A

Gross Profit

$2.60M

N/A

Gross Margin

33.16%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-$36.04M

-4531.7%

EBITDA

-$10.60M

-985.2%

Quarterly Fundamentals

Name

Q3 2022YOY CHG

Total Cash

$962.00K

+842.4%

Total Debt

$141.89M

+3588.4%

Accounts Receivable

$1.95M

N/A

Inventory

$11.88M

N/A

Long Term Debt

$9.57M

+247.9%

Short Term Debt

$132.32M

+11983.7%

Return on Assets

7.50%

N/A

Return on Invested Capital

9.10%

N/A

Free Cash Flow

-$4.78M

-1054.1%

Operating Cash Flow

-$4.60M

-1009.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

INTPIntegrated Pharmaceuticals, Inc.

INTPIntegrated Pharmaceuticals, Inc.$0.00+0.00%

MLTOMEDirect Latino, Inc.

MLTOMEDirect Latino, Inc.$0.00+0.00%

XCRPXcorporeal, Inc.

XCRPXcorporeal, Inc.$0.00+0.00%

BLEVFBeleave Inc.

BLEVFBeleave Inc.$0.00+0.00%

TAUGTauriga Sciences, Inc.

TAUGTauriga Sciences, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NUNu Holdings

NUNu Holdings$15.36+0.10%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$8.61-0.00%

INTCIntel

INTCIntel$102.95-0.02%

ONDSOndas

ONDSOndas$9.47+0.06%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$136.75-0.03%

CAPRCapricor Therapeutics

CAPRCapricor Therapeutics$6.46+0.54%

WETOWetour Robotics

WETOWetour Robotics$7.64+1.11%

Questions About GNRS

What is the current price of Greenrose?

Greenrose is trading at N/A per share.

What is the 52-week range for Greenrose?

Over the past 52 weeks, Greenrose has traded between N/A and N/A.

How much debt does Greenrose have?

As of the most recent reporting period, Greenrose reported total debt of $108.66M.

How much cash does Greenrose have on hand?

Greenrose reported $9.06M in cash and cash equivalents in its most recent financial results.

What is Greenrose’s dividend yield?

Greenrose does not currently have a dividend yield.

Greenrose(OTC) GNRS

Greenrose Financials at a Glance

GNRS News

This Hot New Cannabis SPAC Gives Investors Exposure to Some of the Hottest Markets

This SPAC Is Buying 4 Companies to Build a Vertically Integrated Cannabis Network

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Greenrose

GNRS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Greenrose Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About GNRS

What is the current price of Greenrose?

What is the 52-week range for Greenrose?

How much debt does Greenrose have?

How much cash does Greenrose have on hand?

What is Greenrose’s dividend yield?

Premium Investing Services